Skip to content
Search

Latest Stories

RPS President urges public to support community pharmacy as Amazon eyes local market

Following the reports of Amazon filing trademark for pharmacy in the UK, the Royal Pharmaceutical Society (RPS) today urged the public to continue to support community pharmacies.

Commenting on the news, RPS President Sandra Gidley stressed on the importance of the face-to-face interaction between patients and pharmacists.


“Whilst the public are increasingly buying online, it is vitally important to note that medicines are not normal consumer items. There is real importance and value in the face-to-face interaction between patients and a pharmacist and this must not be lost. Each interaction is an opportunity to make a health intervention and to ensure people have no issues with their medicines and are taking them safely,” she said.

The report on Amazon filing to trademark ‘Amazon Pharmacy’ in three countries including the UK came out earlier this week. It is considered as the company’s initial steps to begin the sale of prescription drugs in these markets.

“Pharmacists see patients when they are well and also spot signs of deteriorating health. I would urge patients and public to continue to support their community pharmacy so that the service is still there when they need it. Community pharmacy does and will continue to play a vital role within our NHS and we will continue to press for better use to be made of the community pharmacy workforce,” Gidley said.

More For You

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less